Vanta Bioscience Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 2, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	139	96	140	404	363	693
Market Cap Growth	-57.10%	-31.51%	-65.44%	11.30%	-47.66%	-32.61%
Enterprise Value	519	400	753	997	816	1,109
Last Close Price	22.07	15.15	22.12	64.00	57.50	109.85
PE Ratio	147.13	88.30	-	-	-	786.08
PS Ratio	7.05	4.84	7.11	4.16	5.78	6.92
PB Ratio	0.66	0.45	3.69	3.11	1.92	2.36
P/TBV Ratio	-	-	-	-	5.25	3.79
P/OCF Ratio	-	-	-	15.05	-	13.14
EV/Sales Ratio	26.25	20.24	38.37	10.25	13.01	11.07
EV/EBITDA Ratio	25.66	19.78	-	75.03	-	29.19
EV/EBIT Ratio	65.58	50.55	-	-	-	44.66
Debt / Equity Ratio	1.80	1.80	18.52	4.70	3.02	1.53
Debt / EBITDA Ratio	18.84	18.84	-	45.87	-	11.81
Net Debt / Equity Ratio	1.79	1.79	18.47	4.69	3.02	1.52
Net Debt / EBITDA Ratio	18.77	18.77	-16.41	45.75	-23.84	11.75
Net Debt / FCF Ratio	-3.14	-3.14	-7.67	-84.35	-1.95	-3.75
Asset Turnover	0.03	0.03	0.02	0.11	0.08	0.13
Inventory Turnover	-	-	0.22	0.12	0.14	0.10
Quick Ratio	0.23	0.23	0.26	0.33	0.12	0.36
Current Ratio	1.20	1.20	0.58	0.75	0.86	1.01
Return on Equity (ROE)	0.87%	0.87%	-158.62%	-53.95%	-43.27%	0.48%
Return on Assets (ROA)	0.65%	0.65%	-6.33%	-2.33%	-3.81%	2.05%
Return on Invested Capital (ROIC)	1.34%	1.19%	-11.77%	-4.23%	-6.75%	2.19%
Return on Capital Employed (ROCE)	1.50%	1.50%	-14.60%	-5.10%	-7.60%	3.70%
Earnings Yield	0.78%	1.13%	-34.20%	-5.73%	-17.86%	0.13%
FCF Yield	-86.80%	-126.45%	-65.19%	-1.78%	-80.77%	-17.16%
Buyback Yield / Dilution	-14.38%	-14.38%	-	-	-	-